Remarkably, the levels of antigen-specific CD8+ T cells trended slightly higher in mice treated with R848 formulated in ABC compared to free or AB formulated R848, though all treated mice had elevated tumor-specific T cell levels in circulation. Here, CD8A is linked to neoplasm.